RxDoctor Payments Data

Mark Jensen, MD

Plastic Surgery · American Fork, UTNPI 1184602351

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.1%), gifts and consulting fees — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Davol Inc. at 36.3% of the total. Reporting peaked in 2019 at $3,153 and has fallen 62.8% since, to $1,174 in 2025.

$11,470in general payments, 2019–2025

Across 254 payments — averaging $45.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Davol Inc.$4K
  • AbbVie$4K
  • Integra Lifesciences Corporation$828
  • Musculoskeletal Transplant Foundation Inc.$637
  • Sientra, Inc.$332
  • TELA Bio, Inc.$300
  • plus $1K from 26 others

What the payments were for

  • Consulting fees$1,62514%
  • Travel & lodging$6376%
  • Food & beverage$5,85651%
  • Gifts$2,70024%
  • Other$6526%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,470 in reported general payments places this provider in the 85th percentile of 71 plastic surgery providers in Utah.

See all plastic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$57,905
Medicare patients
44
Services billed
975

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin21$257
Ondansetron OdtOndansetron28$162
Oxycodone Hcl28$101
Ondansetron Hcl14$95
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$88
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$71

Paid to pharmacies, not to this prescriber.

Other plastic surgery in American Fork

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →